You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
四環醫藥(00460.HK):貝恩資本擬出售韓國肉毒毒素製造商Hugel的控股權益
格隆匯 07-13 22:20

格隆匯7月13日丨四環醫藥(00460.HK)公佈,董事會注意到有關貝恩資本擬出售其於Hugel, Inc("Hugel",一家韓國肉毒毒素製造商,其股份於韓國交易所上市)的控股權益("Hugel股權收購項目")的若干新聞媒體報道。

集團已與Hugel訂立協議,據此,集團具有在中華人民共和國獨家代理Hugel的A型肉毒毒素樂提葆® (Letybo®)及玻尿酸產品的權利。

公司定期探索潛在的戰略業務發展及投資機會,並將考慮尋求符合集團增長戰略及股東利益的投資機會。鑑於集團已取得Hugel若干產品於中國的獨家代理權,並且根據初步評估,董事認為Hugel股權收購項目對集團而言屬潛在的戰略機遇,公司也將進一步積極評估參與Hugel股權收購項目對公司會帶來的潛在價值。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account